 |
Amily |
|
Emily |
|
Lily |
159-2642-3062
服务热线（工作日：9:00-17:30）
武汉老版本彩名堂计划软件生物科技有限公司
热搜词：燕窝酸，不饱和脂肪酸，神经酰胺，花青素，黄酮，皂苷
Wuhan Chemstan Biotechnology Co., Ltd.
武汉老版本彩名堂计划软件生物科技有限公司
-
在线咨询 -
官方邮箱 -
微信下单
-
回到顶部
代谢组学
科研服务
抗体/蛋白
地 址：武汉市东湖新技术开发区高新大道666号，武汉
国家生物产业基地B、C、D区研发楼C1栋
产品销售：15926423062
技术服务：18971263062
E - mail ：info@wxtppt.com
邮 编：430075
化合物单体
老版本彩名堂计划软件生物（Chemstan）所有产品和服务仅用于科学研究，不为任何个人或者非科研性质的用途提供产品和服务。
Copyright @ 武汉老版本彩名堂计划软件生物科技有限公司.All rights reserved
网站建设：中企动力武汉鄂ICP备27143755号-1
浏览量:
产品名称：
Pexidartinib
NO.
2
货号
CS2115
中文名称
Pexidartinib
英文名称
PLX-3397
CAS号
1029044-16-3
产品货号：
CS2115
货期：
现货
价格与订购：
300.00
数量
-
+
库存
200
产品信息
如何订购
产品描述icon
Navoximod (NLG-919, GDC-0919) is a potent indoleamine-(2,3)-dioxygenase (IDO) pathway inhibitor (Ki/EC50: 7 nM/75 nM).
体外活性icon
Using IDO-expressing human monocyte-derived dendritic cells (DCs) in allogeneic mixed lymphocyte reaction (MLR) reactions, Navoximod potently blocks IDO-induced T cell suppression and restores robust T cell responses (ED50: 80 nM). Similarly, using IDO-expressing mouse DCs from tumor-draining lymph nodes, Navoximod abrogates IDO-induced suppression of antigen-specific T cells (OT-I) in vitro (ED50: 120 nM) [1]. Navoximod inhibits the IDO activity in a concentration-dependent manner with an EC50 of 0.95 μM. PEG2k-Fmoc-NLG(L) is less active (EC50: 3.4 μM) in inhibiting IDO compared with free Navoximod while PEG2k-Fmoc-NLG(S) is least active (EC50>10 μM). Coculture of IDO+tumor cells with splenocytes isolated from BALB/c mice leads to significant inhibition of T-cell proliferation. This inhibition is significantly attenuated when the mixed cells are treated with Navoximod. PEG2k-Fmoc-NLG(L) is also active in reversing the inhibitory effect of tumor cells although slightly less potent than Navoximod [3].
产品描述icon
Pexidartinib is a capsule formulation containing a small-molecule receptor tyrosine kinase (RTK) inhibitor of KIT, CSF1R and FLT3 with potential antineoplastic activity.
靶点活性icon
CSF-1R FLT3 Kit
体外活性icon
In M-NFS-60, Bac1.2F5 and M-07e cells, Pexidartinib inhibits the CSF1-dependent proliferation with IC50 of 0.44 μM, 0.22 μMand 0.1 μM, respectively. [1]
体内活性icon
In MMTV-PyMT mice, Pexidartinib (40 mg/kg, p.o.) significantly inhibits both steady-state and PTX-induced tumor infiltration by CD45+CD11b+Ly6C−Ly6 g−F4/80+. Pexidartinib/PTX therapy also results in a significant reduction in CD31+ vessel density within mammary tumors, paralleling induction of apoptosis and necrosis. [1] In C57 mice bearing GL261 tumors, Pexidartinib (p.o.) inhibits glioblastoma invasion. [2] In cmo mice, PLX3397 significantly attenuates autoinflammatory disease by decreasing the erosive bone lesions in tails and paws and the levels of circulating MIP-1α. [3] In mice bearing B16F10 melanomas, Pexidartinib (45 mg/kg, p.o.) enhances CD8-mediated immunotherapy of melanoma. [4]
参考文献icon
1. DeNardo DG, et al. Cancer Discov. 2011, 1(1), 54-67.
2. Coniglio SJ, et al. Mol Med. 2012, 18, 519-527.
3. Chitu V, et al. Blood. 2012, 120(15), 3126-3135.
4. Sluijter M, et al. PLoS One. 2014, 9(8), e104230.
5. Fan K, Li Y, Wang H, et al. Stress-Induced Metabolic Disorder in Peripheral CD4+ T Cells Leads to Anxiety-like Behavior[J]. Cell. 2019, 179(4): 864-879. e19.
别名icon
PLX-3397
纯度icon
99.66%
分子量icon
417.81
分子式icon
C20H15ClF3N5
CAS Noicon
1029044-16-3
存储icon
for short term (days to weeks), or -20℃ for long term (months).
溶解度
icon
icon
DMSO: 77 mg/mL (184.3 mM)
Ethanol: <1 mg/mL
( < 1 mg/ml refers to the product slightly soluble or insoluble )
Note
icon
icon
For research use only .
上一篇
Navoximod
Ivosidenib
下一篇